73 related articles for article (PubMed ID: 22372601)
1. Protein kinase inhibitors in the management of cancer: therapeutic opportunities from natural compounds.
Singh H; Kumar R; Mazumder A
J Asian Nat Prod Res; 2024 Jun; 26(6):663-680. PubMed ID: 38373215
[TBL] [Abstract][Full Text] [Related]
2. Structural Insights on the Role of Halogen Bonding in Protein MEK Kinase-Inhibitor Complexes.
Milesi P; Baldelli Bombelli F; Lanfrancone L; Gomila RM; Frontera A; Metrangolo P; Terraneo G
Chem Asian J; 2024 Apr; 19(7):e202301033. PubMed ID: 38501888
[TBL] [Abstract][Full Text] [Related]
3. Novel 3-Methyleneisoindolinones Diversified via Intramolecular Heck Cyclization Induce Oxidative Stress, Decrease Mitochondrial Membrane Potential, Disrupt Cell Cycle, and Induce Apoptosis in Head and Neck Squamous Cell Carcinoma Cells.
Sharma A; Anand P; Padwad YS; Maurya SK
ACS Omega; 2022 Dec; 7(49):45036-45044. PubMed ID: 36530328
[TBL] [Abstract][Full Text] [Related]
4. Reactions of 3-Hydroxy-2-phenyl-1
Malinowski Z; Fornal E; Stachniuk A; Nowak M
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500412
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor-C in activating vascular endothelial growth factor receptor-3 and chemokine receptor-4 in melanoma adhesion.
Hlophe YN; Joubert AM
J Cell Mol Med; 2022 Dec; 26(23):5743-5754. PubMed ID: 36398426
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors:
Taghour MS; Elkady H; Eldehna WM; El-Deeb NM; Kenawy AM; Elkaeed EB; Alsfouk AA; Alesawy MS; Metwaly AM; Eissa IH
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1903-1917. PubMed ID: 35801403
[TBL] [Abstract][Full Text] [Related]
7. One-pot synthesis of indoles and quinolinones from
Wang J; Pan X; Rong Q; Zhao L; Zhao L; Dai W; Zhao K; Hu L
RSC Adv; 2020 Sep; 10(55):33455-33460. PubMed ID: 35515061
[TBL] [Abstract][Full Text] [Related]
8. Structurally Uncommon Secondary Metabolites Derived from Endophytic Fungi.
Ortega HE; Torres-Mendoza D; Caballero E Z; Cubilla-Rios L
J Fungi (Basel); 2021 Jul; 7(7):. PubMed ID: 34356949
[TBL] [Abstract][Full Text] [Related]
9. New 2-Oxoindolin Phosphonates as Novel Agents to Treat Cancer: A Green Synthesis and Molecular Modeling.
Tiwari SV; Sharif NS; Gajare RI; Vazquez JAS; Sangshetti JN; Damale MD; Nikalje APG
Molecules; 2018 Aug; 23(8):. PubMed ID: 30096835
[TBL] [Abstract][Full Text] [Related]
10. Nanoscale isoindigo-carriers: self-assembly and tunable properties.
Pashirova TN; Bogdanov AV; Musin LI; Voronina JK; Nizameev IR; Kadirov MK; Mironov VF; Zakharova LY; Latypov SK; Sinyashin OG
Beilstein J Nanotechnol; 2017; 8():313-324. PubMed ID: 28243570
[TBL] [Abstract][Full Text] [Related]
11. Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads.
Kaminska KK; Bertrand HC; Tajima H; Stafford WC; Cheng Q; Chen W; Wells G; Arner ES; Chew EH
Oncotarget; 2016 Jun; 7(26):40233-40251. PubMed ID: 27244886
[TBL] [Abstract][Full Text] [Related]
12. Rational modification of semaxanib and sunitinib for developing a tumor growth inhibitor targeting ATP binding site of tyrosine kinase.
Kaur J; Kaur B; Singh P
Bioorg Med Chem Lett; 2018 Jan; 28(2):129-133. PubMed ID: 29208523
[TBL] [Abstract][Full Text] [Related]
13. Discovery and evaluation of 3,5-disubstituted indole derivatives as Pim kinase inhibitors.
More KN; Hong VS; Lee A; Park J; Kim S; Lee J
Bioorg Med Chem Lett; 2018 Aug; 28(14):2513-2517. PubMed ID: 29871845
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vivo SAR study of indolin-2-one-based multi-targeted inhibitors as potential anticancer agents.
Zhang L; Zheng Q; Yang Y; Zhou H; Gong X; Zhao S; Fan C
Eur J Med Chem; 2014 Jul; 82():139-51. PubMed ID: 24904961
[TBL] [Abstract][Full Text] [Related]
15. Multi-kinase inhibitors.
Garuti L; Roberti M; Bottegoni G
Curr Med Chem; 2015; 22(6):695-712. PubMed ID: 25511779
[TBL] [Abstract][Full Text] [Related]
16. Indolinones as promising scaffold as kinase inhibitors: a review.
Prakash CR; Raja S
Mini Rev Med Chem; 2012 Feb; 12(2):98-119. PubMed ID: 22372601
[TBL] [Abstract][Full Text] [Related]
17. How the structural properties of the indole derivatives are important in kinase targeted drug design?: A case study on tyrosine kinase inhibitors.
Mondal D; Amin SA; Moinul M; Das K; Jha T; Gayen S
Bioorg Med Chem; 2022 Jan; 53():116534. PubMed ID: 34864496
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
